Effect of Sinovac on Survival in Intensive Care Unit

Sisli Hamidiye Etfal Training and Research Hospital96 enrolled

Overview

Effect of Inactivated COVID-19 Vaccine (Sinovac) on survival in intensive care unit, Single Center Experience

Turkey has started vaccinate healthcare professionals at 13 January 2021 by Sinovac vaccine and declared a step by step inclusion schedule The primary aim of the study is to compare clinical, laboratory and survival data of COVID-19 patients who were vaccinated at least 14 days before enrollment to the study with COVID-19 patients not vaccinated although they would have. The secondary aim is to compare age of enrolled patients to ICU due to SARS-CoV-2 infection with patients admitted to ICU before start of vaccination program.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Survival Intensive Care Unit

Eligibility

Sex: ALLMin age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with covid 19 over the age of 65 who were admitted to the intensive care unit between 1 April 2021 and 15 May 2021 Exclusion Criteria: * admissions to ICU due to reasons other than COVID-19, age younger than 65, continued admission at the end of enrolment date,

Locations (1)

Sisli Hamidiye Etfal Research and Training Hospital

Istanbul, Turkey (Türkiye)

Outcomes

Primary Outcomes

survival data

If the patient dies, we have reached an outcome

Time frame: 30 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.